Transfer of data across borders presents a particular compliance challenge for companies in China. Xiangxiang Ma, a partner of Anjie Broad Law Firm, analyses a new document which brings welcome practical clarification to this area
China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.
Jianwei (Jerry) Fang, Xiaoyu (Arthur) Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s Unreliable Entity List, as well as compliance recommendations for multinational corporations
A compliance audit is required when processing personal information of more than 10 million persons / CLP Reference: 5600/25.02.12 ; Promulgated: 2025-02-12; Effective: 2025-05-01
China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance audits for companies; and AI company loses against Reuters in U.S. summary judgment with key implication
Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025
Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises
